NCT04722913 Relation Between Cervicogenic Headache and Forward Head Posture
| NCT ID | NCT04722913 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cairo University |
| Condition | Cervicogenic Headache |
| Study Type | OBSERVATIONAL |
| Enrollment | 400 participants |
| Start Date | 2024-12-10 |
| Primary Completion | 2025-01-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 400 participants in total. It began in 2024-12-10 with a primary completion date of 2025-01-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will be designed to determining whether there is a relationship between CGH and cervical posture which may potentially provide physical therapists with evidence supporting the assessment and treatment of abnormal posture in this patient group.
Eligibility Criteria
Inclusion Criteria: 1. Subjects with Craniovertebral angle (CVA) less than 50 degrees. (Gavin Morrison, 2018). 2. University students who were taking consecutive lectures for 3 hours and who worked forward for 3 hours or more on laptop (Arfa Naz et al, 2018). Exclusion Criteria: 1. History of significant medical conditions that might be potential contraindications to physical examination of the cervical spine, including known cancer, osteoporosis, nerve root symptoms, inflammatory or infectious diseases affecting the neck instability of the cervical spine, or reported potential vertebrobasilar insufficiency symptoms (Peter K. Farmer et al, 2015). 2. History of cervical spine injures (fracture, sprain, strain, whiplash), cervical spondylosis, obvious spinal deformities, neurological and neuromuscular disorders, TMJ dysfunction, cervicothoracic and lumbar kyphoscoliosis, rheumatic disease, torticollis, and balance disorders (B. Shaghayegh fard et al, 2015).
Contact & Investigator
Yasser Ramzy, Professor
STUDY DIRECTOR
Cairo University
Frequently Asked Questions
Who can join the NCT04722913 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 25 Years, studying Cervicogenic Headache. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04722913 currently recruiting?
Yes, NCT04722913 is actively recruiting participants. Contact the research team at mernaibrahim00@gmail.com for enrollment information.
Where is the NCT04722913 trial being conducted?
This trial is being conducted at Giza, Egypt.
Who is sponsoring the NCT04722913 clinical trial?
NCT04722913 is sponsored by Cairo University. The principal investigator is Yasser Ramzy, Professor at Cairo University. The trial plans to enroll 400 participants.